Related Experiment Video
Updated: Jul 19, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Aerosol deposition in the upper airways of a child
F H C de Jongh1, M J G Rinkel, H W M Hoeijmakers
1Engineering Fluid Dynamics, University of Twente, Enschede, The Netherlands. f.h.c.dejongh@utwente.nl
Insights
Computational fluid dynamics modeling of aerosol deposition in a child's upper airways shows accurate results for small flow rates. However, higher flow rates and smaller particle sizes led to deviations, likely due to model limitations.
Area of Science:
- Pediatric respiratory research
- Computational fluid dynamics (CFD)
- Aerosol science
Background:
- Inhaled aerosols primarily deposit in the upper airways of young children.
- Accurate modeling of aerosol deposition is crucial for understanding respiratory health in pediatrics.
Purpose of the Study:
- To model aerosol particle deposition in the upper airways of a 9-month-old child.
- To validate computational fluid dynamics (CFD) simulations against analytical and experimental data.
Main Methods:
- Created a 3D upper airway model from CT scan data of a 9-month-old child.
- Employed computational fluid dynamics (CFD) software (CFX) for aerosol deposition simulations.
- Validated CFD model using analytical solutions for sedimentation and inertial impaction test cases.
Main Results:
- CFD model showed deviations for small particles (<3 micron) in validation tests due to mesh-generated velocities.
- Simulations of 3.7-micron particle deposition in the child's airway model (SAINT-model) matched experimental data at low flow rates.
- Significant discrepancies observed at higher flow rates and for smaller particle sizes.
Conclusions:
- The SAINT-model provides a reasonable approximation for aerosol deposition at low physiological conditions.
- Limitations in modeling the nasal entrance and accounting for turbulence-induced inertial effects may explain deviations at higher flow rates.
Abstract:
In a small child, normally only a small amount of inhaled aerosol particles reaches the lungs because the majority deposits in the upper airways. In this study, the upper airways of a 9- month-old child, based on computed tomography (CT) data, are modeled to serve as input for a computational fluid dynamics package (CFX). Verification of the validity of aerosol deposition calculations by this package is accomplished by evaluating two test cases, which also can be solved analytically. The numerically found sedimentation fraction in a horizontally placed straight pipe shows deviations from the exact solution for small particle sizes (less than 3 micron) due to small velocities generated by the use of an unstructured mesh. Although these velocities are small compared to the mainstream velocity, they are comparable with the terminal settling velocity of such a particle. Also the test case for inertial impaction in a bend pipe demonstrated the same problem. With this in mind, the aerosol deposition of 3.7-micron particles in the upper airway model of the child (SAINT-model) was calculated. Results were compared with experimentally found results in the literature. For small tidal volumes and flow rates, the computational results matched the experimentally measured results. However, large deviations were found for higher flow rates and small particle sizes. Most probably the incompletely modeled entrance at the nose and inertial effects due to turbulence might be responsible.
Related Concept Videos
Inhaled Medications
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Breathing
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Pulmonary Cycle: Exhalation
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
